Development and validation a simple scoring system to identify malignant pericardial effusion
BackgroundMalignant pericardial effusion (MPE) is a serious complication in patients with advanced malignant tumors, which indicates a poor prognosis. However, its clinical manifestations lack specificity, making it challenging to distinguish MPE from benign pericardial effusion (BPE). The aim of th...
Main Authors: | Xiaxia Jin, Lingling Hu, Meidan Fang, Qiaofei Zheng, Yuan Yuan, Guoguang Lu, Tao Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.1012664/full |
Similar Items
-
Safety and feasibility of thoracoscopic pericardial window in recurrent pericardial effusion – A single-centre experience
by: Mohan Venkatesh Pulle, et al.
Published: (2024-01-01) -
A case series of malignant pericardial effusion
by: Reshma S Babu, et al.
Published: (2022-01-01) -
Outcomes of Patients with and without Malignancy Undergoing Percutaneous Pericardiocentesis for Pericardial Effusion
by: Chun-Ting Shih, et al.
Published: (2021-11-01) -
The Prognostic Impact of Pericardial Fluid Cytology in Malignant Pericardial Effusion
by: Burak Sezenöz, et al.
Published: (2023-01-01) -
PERICARDIAL EFFUSION IN HIV-INFECTED PATIENT
by: E. V. Filippov, et al.
Published: (2014-07-01)